Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis

MS Maurer, P Elliott, R Comenzo, M Semigran… - Circulation, 2017 - Am Heart Assoc
Advances in cardiac imaging have resulted in greater recognition of cardiac amyloidosis in
everyday clinical practice, but the diagnosis continues to be made in patients with late-stage …

Patient selection for ventricular assist devices: a moving target

LW Miller, M Guglin - Journal of the American College of Cardiology, 2013 - jacc.org
The number of patients with advanced heart failure that has become unresponsive to
conventional medical therapy is increasing rapidly. One of the most promising new …

Treatment for chronic heart failure in the elderly: current practice and problems

P Abete, G Testa, D Della-Morte, G Gargiulo… - Heart failure …, 2013 - Springer
Abstract Treatment for chronic heart failure (CHF) is strongly focused on evidence-based
medicine. However, large trials are often far away from the “real world” of geriatric patients …

Current status of left ventricular assist device therapy

P Sajgalik, A Grupper, BS Edwards, SS Kushwaha… - Mayo Clinic …, 2016 - Elsevier
Congestive heart failure (HF) remains a serious burden in the Western World. Despite
advances in pharmacotherapy and resynchronization, many patients have progression to …

Assessment and treatment of right ventricular failure

MA Simon - Nature Reviews Cardiology, 2013 - nature.com
Right ventricular (RV) failure is a complex problem with poor outcomes. Diagnosis requires
a high degree of clinical suspicion, because many of the signs and symptoms of this …

Bridge to removal: a paradigm shift for left ventricular assist device therapy

CH Selzman, JL Madden, AH Healy… - The Annals of thoracic …, 2015 - Elsevier
Ventricular assist devices have become standard therapy for patients with advanced heart
failure either as a bridge to transplantation or destination therapy. Despite the functional and …

Limitations to chronic right ventricular assist device support

JH Karimov, G Sunagawa, D Horvath… - The Annals of thoracic …, 2016 - Elsevier
Failure of the right ventricle represents a significant clinical problem and may have different
causes, with rates varying between 5% and 50% in patients supported by a left ventricular …

Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket …

M Goda, S Jacobs, F Rega, K Peerlinck… - The Journal of Heart and …, 2013 - Elsevier
BACKGROUND: Bleeding complications are frequent adverse events in patients supported
with axial continuous-flow pumps. Previous retrospective studies demonstrated that …

Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging

ES Ketchum, AF Jacobson, JH Caldwell… - Journal of Nuclear …, 2012 - Elsevier
Abstract Background The Seattle Heart Failure Model (SHFM) is a multivariable model that
uses demographic and clinical markers to predict survival in patients with heart failure …

Can mechanical circulatory support be an effective treatment for HFpEF patients?

E Gude, AE Fiane - Heart Failure Reviews, 2023 - Springer
Heart failure with preserved ejection fraction (HFpEF) is increasing in prevalence and
represents approximately 50% of all heart failure (HF) patients. Patients with this complex …